Scientists from UCLA (University of California, Los Angeles), used the blood of healthy volunteers and those without skin conditions to test resveratrol’s ability to inhibit the growth of acne-causing bacteria.
The researchers’ paper, Resveratrol Demonstrates Antimicrobial Effects Against Propionibacterium acnes In Vitro, was published in the journal Dermatology and Therapy, describing acne as a skin disease that affects 85 per cent of adolescents and 10 per cent of adults. They also said that the "economic burden" to fight acne totals more than $3 billion each year and said that monotherapy and overuse of antibiotics had created a resistance against the treatment, while retinoids and benzoyl peroxide (found in creams and gels) often cause irritation.
